FDA Clinical Outcome Assessments and CDISC QRS supplements: Enabling Patient-Centric Drug Development

FDA Clinical Outcome Assessments and CDISC QRS supplements: Enabling Patient-Centric Drug Development

LAP Lambert Academic Publishing

Pages: 64, Paperback, LAP Lambert Academic Publishing

Compare prices (1 shop)

shop Price Action
33,12 GBP Go to shop